The information you provide to the chat will be collected and recorded to improve your experience and for quality assurance. Please read our privacy policy to see how we are storing and protecting your data.
How can we help you today?
Discover our new oral solid dose (OSD) development capabilities at our Bend, Oregon site.
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Recent searches
Clear History
Suggestions
All Results
Search
US | EN
Maximizing value across drug development: Embracing a new CDMO and CRO partnership approach
Webinar On Demand
Pharma and biotech companies are facing increased competition and rising costs, alongside the ongoing pressure to deliver innovative therapies faster than ever. With R&D expenses climbing and funding often limited, organizations are rethinking how they approach drug development to maximize efficiency and value at every stage, from preclinical research to commercialization.
In this on-demand webinar, industry experts from Thermo Fisher Scientific and Tufts explore key insights from preliminary findings by the Tufts Center for the Study of Drug Development, and discuss how integrating CDMO and CRO services and solutions under one comprehensive model can significantly impact the expected Net Present Value (eNPV) of drug development programs.
Watch the on-demand webinar to learn how Thermo Fisher Scientific’s AcceleratorTM Drug Development, 360° CDMO and CRO services can improve efficiency, reduce timelines, and help deliver high-quality therapies to patients faster.
Key takeaways include:
- Financial and operational benefits of leveraging eNPV modeling for combined CDMO and CRO services
- Simplifying the development journey with Thermo Fisher Scientific’s Accelerator™ Drug Development
- Case studies of biotech and pharma companies successfully accelerating their path from lab to patient